BREAKING
Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 2 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 2 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 3 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 3 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 3 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 3 days ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 2 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 2 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 3 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 3 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 3 hours ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 3 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 3 days ago
ADVERTISEMENT
AlphaGraphs

Key highlights from Pfizer (PFE) Q3 2021 earnings results

Pfizer Inc. (NYSE: PFE) reported third quarter 2021 earnings results today. Revenues more than doubled year-over-year to $24 billion. Reported net income was $8.1 billion, or $1.42 per share, compared to $1.4 billion, or $0.26 per share, in the year-ago period. Adjusted net income more than doubled YoY to $7.6 billion, or $1.34 per share. […]

$PFE November 2, 2021 1 min read

Pfizer Inc. (NYSE: PFE) reported third quarter 2021 earnings results today.

Revenues more than doubled year-over-year to $24 billion.

Reported net income was $8.1 billion, or $1.42 per share, compared to $1.4 billion, or $0.26 per share, in the year-ago period. Adjusted net income more than doubled YoY to $7.6 billion, or $1.34 per share.

Both revenue and earnings beat expectations.

The company raised its guidance for the full year of 2021 and now expects revenue to range between $81-82 billion and adjusted EPS to range between $4.13-4.18. This compares to the previous outlook for revenue of $78-80 billion and adjusted EPS of $3.95-4.05.

ADVERTISEMENT

Prior performance

ADVERTISEMENT